Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Sertoli-leydig cell tumors


Other Names for this Disease
  • Arrhenoblastoma
  • Androblastoma of ovary
  • Sertoli-leydig cell tumor of the ovary
  • Arrhenoblastoma of ovary
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

Treatment

Newline Maker

How might a Sertoli-Leydig cell tumor of the ovary be treated?

Because Sertoli-Leydig cell tumors of the ovary are rare, there are no established guidelines for treatment.  Treatment decisions are based on the unique characteristics of each tumor, particularly the stage.  Surgery to remove the tumor is considered the best treatment for an early-stage tumor, whereas surgery and chemotherapy may be needed to treat a later-stage tumor.[1][2]
Last updated: 1/1/2013

References
  1. Gui T, Cao D, Shen K, Yang J, Zhang Y, Yu Q, Wan X, Xiang Y, Xiao Y, Guo L. A clinicopathological analysis of 40 cases of ovarian Sertoli-Leydig cell tumors. Gynecologic Oncology. 2012; 127:384-389. http://www.ncbi.nlm.nih.gov/pubmed/22850410. Accessed 1/1/2013.
  2. Sigismondi C, Gadducci A, Lorusso D, Candiani M, Breda E, Raspagliesi F, Cormio G, Marinaccio M, Mangili G. Ovarian Sertoli-Leydig cell tumors. a retrospective MITO study. Gynecologic Oncology. 2012; 125:673-676. http://www.ncbi.nlm.nih.gov/pubmed/22446621. Accessed 1/1/2013.


Clinical Trials & Research for this Disease

  • ClinicalTrials.gov lists trials that are studying or have studied Sertoli-leydig cell tumors. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.
Other Names for this Disease
  • Arrhenoblastoma
  • Androblastoma of ovary
  • Sertoli-leydig cell tumor of the ovary
  • Arrhenoblastoma of ovary
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.